Two Way Crossover Oral Drug-drug Interaction Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug) in Healthy Adult Human Subjects Under Fasting Condition
An open label, balanced, randomized, single-dose, two-treatment, two-sequence, two-period, crossover oral drug-drug interaction study of spironolactone (perpetrator) and Digoxin (substrate drug) in healthy adult human subjects under fasting condition.
100 Clinical Results associated with Cmp Development Sdn. Bhd.
0 Patents (Medical) associated with Cmp Development Sdn. Bhd.
100 Deals associated with Cmp Development Sdn. Bhd.
100 Translational Medicine associated with Cmp Development Sdn. Bhd.